Price Alert

Guardant Health Inc. (GH)

NASDAQ: GH · Real-Time Price · USD

59.50

-0.86 (-1.42%)

At close: Aug 15, 2025, 11:12 AM

Guardant Health Statistics

Share Statistics

Guardant Health has 124.71M shares outstanding. The number of shares has increased by 0.7% in one year.

Shares Outstanding	124.71M
Shares Change (YoY)	0.7%
Shares Change (QoQ)	0.38%
Owned by Institutions (%)	95.08%
Shares Floating	118.53M
Failed to Deliver (FTD) Shares	192
FTD / Avg. Volume	0.01%

Short Selling Information

The latest short interest is 9.58M, so 7.73% of the outstanding shares have been sold short.

Short Interest	9.58M
Short % of Shares Out	7.73%
Short % of Float	8.12%
Short Ratio (days to cover)	5.49

Valuation Ratios

The PE ratio is -8.59 and the forward PE ratio is -21. Guardant Health's PEG ratio is 0.51.

PE Ratio	-8.59
Forward PE	-21
PS Ratio	5.07
Forward PS	6.1
PB Ratio	-26.85
P/FCF Ratio	-13.64
PEG Ratio	0.51

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Guardant Health.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.68, with a Debt / Equity ratio of -9.57.

Current Ratio	4.68
Quick Ratio	4.36
Debt / Equity	-9.57
Debt / EBITDA	-3.42
Debt / FCF	-4.86
Interest Coverage	-171.87

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$369.69K
Profits Per Employee	$-218.3K
Employee Count	1,999
Asset Turnover	0.5
Inventory Turnover	4.08

Taxes

Income Tax	1.28M
Effective Tax Rate	-0.3%

Stock Price Statistics

The stock price has increased by 79.88% in the last 52 weeks. The beta is 1.44, so Guardant Health's price volatility has been higher than the market average.

Beta	1.44
52-Week Price Change	79.88%
50-Day Moving Average	47.68
200-Day Moving Average	40.92
Relative Strength Index (RSI)	66.67
Average Volume (20 Days)	2,330,659

Income Statement

In the last 12 months, Guardant Health had revenue of 739.02M and earned -436.37M in profits. Earnings per share was -3.56.

Revenue	739.02M
Gross Profit	449.22M
Operating Income	-443.59M
Net Income	-436.37M
EBITDA	-390.12M
EBIT	-432.51M
Earnings Per Share (EPS)	-3.56

Full Income Statement

Balance Sheet

The company has 525.54M in cash and 1.34B in debt, giving a net cash position of -810.51M.

Cash & Cash Equivalents	525.54M
Total Debt	1.34B
Net Cash	-810.51M
Retained Earnings	-2.58B
Total Assets	1.33B
Working Capital	645M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -239.86M and capital expenditures -35.09M, giving a free cash flow of -274.94M.

Operating Cash Flow	-239.86M
Capital Expenditures	-35.09M
Free Cash Flow	-274.94M
FCF Per Share	-2.24

Full Cash Flow Statement

Margins

Gross margin is 60.79%, with operating and profit margins of -60.02% and -59.05%.

Gross Margin	60.79%
Operating Margin	-60.02%
Pretax Margin	-58.87%
Profit Margin	-59.05%
EBITDA Margin	-52.79%
EBIT Margin	-60.02%
FCF Margin	-37.2%

Dividends & Yields

GH does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for GH is $60, which is 9.5% higher than the current price. The consensus rating is "Buy".

Price Target	$60
Price Target Difference	9.5%
Analyst Consensus	Buy
Analyst Count	15

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	-0.45
Piotroski F-Score	3